LOGIN  |  REGISTER

Recent Insider Transactions - VYNE Therapeutics (NASDAQ: VYNE)

Follow NASDAQ:VYNE Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: CHIEF FINANCIAL OFFICER
04/01/2024
Sell
$3.08
94
$290
131,743
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: CHIEF SCIENTIFIC OFFICER
04/01/2024
Sell
$3.08
157
$484
133,741
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: CHIEF LEGAL OFFICER AND GC
04/01/2024
Sell
$3.08
161
$496
149,274
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: PRESIDENT AND CEO
04/01/2024
Sell
$3.08
1,004
$3K
494,160
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
01/02/2024
Sell
$2.28
93
$212
131,837
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
01/01/2024
Buy
$2.33
62,500
$146K
62,500
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
01/02/2024
Sell
$2.28
157
$358
133,898
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
01/01/2024
Buy
$2.33
62,500
$146K
62,500
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
01/02/2024
Sell
$2.28
161
$367
149,435
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
01/01/2024
Buy
$2.33
62,500
$146K
62,500
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
01/02/2024
Sell
$2.28
1,004
$2K
495,164
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
01/01/2024
Buy
$2.33
225,000
$524K
225,000
NASDAQ VYNE VYNE Therapeutics
Sandoval Elisabeth / director
01/01/2024
Buy
$2.33
20,000
$47K
20,000
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
01/01/2024
Buy
$2.33
20,000
$47K
20,000
NASDAQ VYNE VYNE Therapeutics
Bruno Anthony D / director
01/01/2024
Buy
$2.33
20,000
$47K
20,000
NASDAQ VYNE VYNE Therapeutics
Basta Steven L / director
01/01/2024
Buy
$2.33
20,000
$47K
20,000
NASDAQ VYNE VYNE Therapeutics
BARBARI SHARON / director
01/01/2024
Buy
$2.33
20,000
$47K
20,000
NASDAQ VYNE VYNE Therapeutics
Borowski Christine / director
01/01/2024
Buy
$2.33
40,000
$93K
40,000
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
12/13/2023
Buy
$2.70
62,500
$169K
62,500
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
12/13/2023
Buy
$2.70
62,500
$169K
62,500
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
12/13/2023
Buy
$2.70
62,500
$169K
62,500
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
12/13/2023
Buy
$2.70
225,000
$608K
225,000
NASDAQ VYNE VYNE Therapeutics
Sandoval Elisabeth / director
12/13/2023
Buy
$2.70
20,000
$54K
20,000
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
12/13/2023
Buy
$2.70
20,000
$54K
20,000
NASDAQ VYNE VYNE Therapeutics
Bruno Anthony D / director
12/13/2023
Buy
$2.70
20,000
$54K
20,000
NASDAQ VYNE VYNE Therapeutics
Basta Steven L / director
12/13/2023
Buy
$2.70
20,000
$54K
20,000
NASDAQ VYNE VYNE Therapeutics
BARBARI SHARON / director
12/13/2023
Buy
$2.70
20,000
$54K
20,000
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
11/30/2023
Buy
$2.81
2,284
$6K
46,168
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
11/15/2023
Buy
$3.91
13,000
$51K
36,472
NASDAQ VYNE VYNE Therapeutics
AI Biotechnology LLC / 10 percent owner
11/01/2023
Sell
$0.0001
7.79M
$779
0
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
10/02/2023
Sell
$3.83
1,087
$4K
6,930
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
10/02/2023
Sell
$3.83
1,184
$5K
9,055
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
10/02/2023
Sell
$3.83
1,154
$4K
24,596
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
10/02/2023
Sell
$3.83
8,549
$33K
43,884
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
06/30/2023
Sell
$4.10
91
$373
8,017
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
06/30/2023
Sell
$4.10
151
$619
10,239
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
06/30/2023
Sell
$4.10
157
$644
25,750
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
06/30/2023
Sell
$4.10
981
$4K
52,433
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
05/31/2023
Buy
$3.46
3,664
$13K
25,907
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
05/31/2023
Buy
$3.46
2,766
$10K
53,414
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
03/31/2023
Sell
$3.08
384
$1K
8,108
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
03/31/2023
Sell
$3.08
480
$1K
10,390
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
03/31/2023
Sell
$3.08
478
$1K
22,243
NASDAQ VYNE VYNE Therapeutics
Domzalski David / director, officer: President and CEO
03/31/2023
Sell
$3.08
2,734
$8K
50,648
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
03/20/2023
Buy
$2.48
20,000
$50K
23,472
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
03/20/2023
Buy
$2.50
10,000
$25K
22,721
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
12/31/2022
Sell
$0.15
1,813
$272
229,144
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
12/31/2022
Sell
$0.15
1,720
$258
220,252
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: Chief Financial Officer
12/31/2022
Sell
$0.15
354
$53
173,005
NASDAQ VYNE VYNE Therapeutics
Domzalski David / officer: President and CEO
12/31/2022
Sell
$0.15
10,685
$2K
1.06M
NASDAQ VYNE VYNE Therapeutics
Domzalski David / officer: President and CEO
11/30/2022
Buy
$0.20
34,705
$7K
1.07M
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: CFO
09/30/2022
Sell
$0.22
353
$79
173,359
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
09/30/2022
Sell
$0.22
1,719
$383
221,972
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
09/30/2022
Sell
$0.22
1,813
$404
230,957
NASDAQ VYNE VYNE Therapeutics
Domzalski David / officer: President and CEO
09/30/2022
Sell
$0.22
10,683
$2K
1.04M
NASDAQ VYNE VYNE Therapeutics
Sandoval Elisabeth / director
08/10/2022
Buy
$0.31
20,500
$6K
20,500
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
08/10/2022
Buy
$0.31
20,500
$6K
20,500
NASDAQ VYNE VYNE Therapeutics
Bruno Anthony D / director
08/10/2022
Buy
$0.31
20,500
$6K
20,500
NASDAQ VYNE VYNE Therapeutics
BARBARI SHARON / director
08/10/2022
Buy
$0.31
20,500
$6K
20,500
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: CFO
06/30/2022
Sell
$0.39
354
$138
173,712
NASDAQ VYNE VYNE Therapeutics
Stuart Iain / officer: Chief Scientific Officer
06/30/2022
Sell
$0.39
1,719
$669
223,691
NASDAQ VYNE VYNE Therapeutics
Harsch Mutya / officer: Chief Legal Officer and GC
06/30/2022
Sell
$0.39
1,813
$705
232,770
NASDAQ VYNE VYNE Therapeutics
Domzalski David / officer: President and CEO
06/30/2022
Sell
$0.39
10,683
$4K
1.05M
NASDAQ VYNE VYNE Therapeutics
Zeronda Tyler / officer: CFO
05/31/2022
Buy
$0.35
12,510
$4K
174,066
NASDAQ VYNE VYNE Therapeutics
Domzalski David / officer: President and CEO
05/31/2022
Buy
$0.35
11,887
$4K
1.06M

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous